Trump's Crypto Blueprint Unveils This Infrastructure Powerhouse

One blockchain token sits at the heart of Washington's pro-crypto agenda. Institutions are loading up while it still trades at a discount. Here's how to get in for $3.

BMRN
Biomarin Pharmaceutical Inc
NASDAQ
60.32
Open 59.00 Prev Close 59.82
High 60.32 Low 59.00
Volume 107 Volume (Avg) 1,698
52 Week High 94.85 52 Week Low 52.93
Market Cap 11.6B PE Ratio 22.38

Shares Stats

Shares Outstanding191,760,000
Shares Float189,180,000
Shares Short5,080,000
Insider Holdings82%
Institution Holdings98.04%

About Biomarin Pharmaceutical Inc

BioMarin Pharmaceutical Inc., a biotechnology company, engages in the development and commercialization of therapies for life-threatening rare diseases and medical conditions in the United States, Europe, Latin America, the Middle East, the Asia Pacific, and internationally. The company's products include VIMIZIM, an enzyme replacement therapy for the treatment of mucopolysaccharidosis (MPS) IV type A, a lysosomal storage disorder; VOXZOGO, a once daily injection analog of c-type natriuretic peptide (CNP) for the treatment of achondroplasia; NAGLAZYME, a recombinant form of N- acetylgalactosamine 4-sulfatase for patients with MPS VI; and PALYNZIQ, a PEGylated recombinant phenylalanine (Phe) ammonia lyase enzyme delivered through subcutaneous injection to reduce blood Phe concentrations. It also develops BRINEURA, a recombinant human tripeptidyl peptidase 1 for the treatment of patients with ceroid lipofuscinosis type 2, a form of Batten disease; ALDURAZYME, a purified protein designed to be identical to a naturally occurring form of the human enzyme alpha-L-iduronidase; KUVAN, a proprietary synthetic oral form of 6R-BH4 that is used to treat patients with phenylketonuria, an inherited metabolic disease; and ROCTAVIAN, an adeno associated virus vector for the treatment of severe hemophilia A. The company's products under development include BMN 333, a longer-acting CNP for the treatment of multiple growth disorders, such as achondroplasia and hypochondroplasia; BMN 349, an oral therapeutic for the treatment of liver disease associated with alpha-1 antitrypsin deficiency; and BMN 351, an oligonucleotide for the treatment of duchenne muscular dystrophy. It serves specialty pharmacies, hospitals, non-U.S. government agencies, distributors, and pharmaceutical wholesalers. The company has license and collaboration agreements with Catalyst Pharmaceutical Partners, Inc., and Ares Trading S.A. The company was incorporated in 1996 and is based in San Rafael, California.

General

NameBiomarin Pharmaceutical Inc
TickerBMRN
ExchangeNASDAQ
SectorHealthcare
IndustryBiotechnology
CurrencyUSD
CountryUSA
Fiscal Year EndDecember
Full Time Employees3,040

Highlights

Analyst Target96.92
Market Cap11,567,900,000
PE Ratio22.38
PEG Ratio0.42
EBITDA806,617,984

Financials

Curr Year EPS Estimate4.31
Next Quarter EPS Estimate1.03
Profit Margin17.93%
Operating Margin21.44
Return on Assets0.06
Return on Equity0.10
Revenue2.9B
Earnings Per Share2.70
Revenue Per Share15.48
Gross Profit2,389,870,080
Quarterly Revenue Growth0.15

Valuation

Trailing PE22.97
Forward PE15.53
Price/Sales (Trailing 12 Mt.)4.03
Price/Book (Most Recent Quarter)2.05

Earnings

Most Popular

Warren Buffett's Top Stock Picks Now Come With a 15% Income Bonus Through This Fund

A new ETF is offering investors the chance to follow in the footsteps of one of the world's most successful investors and earn income at the same time.

Why Barrick Gold Stock Is Trading Lower

Barrick Gold Corp (NYSE:GOLD) shares are trading lower by 4.5% to $19.08 during Wednesday’s session.

A New Gold Discovery in Red Lake? - Ad

Two new gold anomalies just lit up the maps. They sit right beside a restart-ready mine-and follow the exact fold pattern that's made Red Lake world famous.

Canadians put off by Trump's bluster and border arrests are booking far fewer US visits

VANCOUVER, British Columbia (AP) — Diana and Rick Bellamy initially planned to take a Caribbean cruise out of Houston before heading to Laurel, Mississippi, to visit the home of one of their favorite HGTV shows, “Home Town.”

Yale Classmates Urge Bessent To Reconsider Trump White House Role — Treasury Secretary Calls It an 'Honor'

A group of Yale University alumni publicly appealed to Treasury Secretary Bessent, urging him to reevaluate his position within the Trump administration.

You Can Take a Stake in Elon's xAI Before June 1st... - Ad

Elon Musk's private AI firm xAI may have just leapfrogged ChatGPT and Google's Gemini--building what experts call the future of AI. For the first time, you can take a stake starting at $500.

Gold's Historic Surge Unlocking Value in These Mining Stocks

Surging gold prices have amplified the profitability of global gold mining companies. Here are some stocks to consider.

Tesla Stock Skyrockets 20% Following Elon Musk's Return and Shift From DOGE

Tesla shares have experienced a 20% surge following the announcement of CEO Elon Musk's return to the company.

Biggest Dividend Payout in U.S. History: $1 Trillion up for Grabs! - Ad

Trump just launched a $1 trillion National Investment Fund to replace income taxes and send direct payouts to Americans. You could claim up to $21,307--before the first public checks go out. This is historic. Act now to be first in line.

UPS to cut 20,000 jobs, close some facilities as it reduces amount of Amazon shipments it handles

UPS is looking to slash about 20,000 jobs and close more than 70 facilities as it drastically reduces the amount of Amazon shipments it handles.

Brace Yourself for Jeff Bezos' "Amazon Helios" - Ad

Amazon delivers 20 million packages a day... powers some of the most popular websites... delivers medication to half of the U.S. population... and even produces award-winning films and TV shows. But a Wall Street legend -- twice featured on 60 Minutes -- predicts that "Amazon Helios" will be bigger than all of those... COMBINED.

Cathie Wood Bets Against Mark Zuckerberg's Meta Ahead Of Crucial Earnings Report, Loads Up On This Amazon Rival

Cathie Wood's Ark Invest shuffled its portfolio on Tuesday, April 29, 2025, selling Meta shares ahead of earnings while buying into AMD, Shopify, and several biotech names.

Activists to rally worldwide on May Day, with US protests targeting Trump policies

CHICAGO (AP) — From worker rights rallies to marches for social justice, activists around the globe will kick off demonstrations on Thursday.

Elon Musk Drops Stunning Bombshell? - Ad

Behind closed doors, Musk revealed a game-changing breakthrough technology that could shake the tech world & crush major companies. Why is no one talking about it? Luckily, we had a man on the inside - watch now to see the details & how to profit!

Eli Lilly Set To Report Earnings As Investors Eye Weight Loss Drug Momentum

Eli Lilly (LLY) will report Q1 results on Thursday. Analysts expect in line results with focus on tirizepatide and obesity franchise.

A massive explosion and fire strikes Iranian port and injures at least 281 people

TEHRAN, Iran (AP) — The number of injured from an explosion Saturday at a port in southern Iran jumped to 281, the state-run IRNA news agency reported.

No.1 Opportunity for 2025 [Take Action Now!] - Ad

Starlink's potential IPO Could Be the Biggest in History--Silicon Valley insider James Altucher has uncovered a way to profit BEFORE the IPO--with as little as $50. Musk's $180B giant is set to launch--will you miss out? Claim your spot before it's too late.

Trump's AI Education Push, Cramer's AI Stock Optimism, And More: This Week In Artificial Intelligence

Week full of AI news: Trump advocates for AI education, Cramer bullish on AI stocks, Amazon and Nvidia dismiss data center fears, OpenAI's restructuring raises concerns, Nadella's Microsoft introduces AI updates.

Forget Dogecoin And Shiba Inu — Crypto Analyst Sees This Coin Surging 100%

A crypto analyst has forecasted a 100% increase for Pepe (CRYPTO: PEPE), a mid-cap competitor to Dogecoin (CRYPTO: DOGE) and Shiba Inu (CRYPTO:

The Cross-Chain Giant Set for 1,000%+ Gains - Ad

This multi-chain protocol's volume is exploding while its price is still under the radar. Institutions are moving in fast-get our urgent report before retail wakes up.

Musk's Ex-Wife Opens Up About Why Life With Elon Was So Difficult

Justine Wilson recently shed light on the complexities of their marriage and the challenges she faced being married to the Tesla CEO.

Nvidia Is About to Shock the World: July 23rd - Ad

Jeff Brown, the tech legend who picked shares of Nvidia in 2016 before they jumped by more than 22,000%, is warning everyone to... Mark this date on your calendar: July 23rd! That's when Nvidia could help send shares of this Elon Musk supplier skyrocketing higher.

Swiss leader says Trump administration foresees 'privileged' talks with 15 countries on US tariffs

GENEVA (AP) — The Swiss president says Switzerland is among 15 countries with which the United States plans to conduct “privileged” negotiations to help reach a deal in the wake of sweeping U.S. tariffs on dozens of countries that have shaken global markets.

Executive Order 14179 Could Change Social Security Forever - Ad

President Trump's inner circle has a plan that could radically change how Social Security works. In fact, just days after taking office, President Trump signed Executive Order 14179 - giving his team new powers to permanently reset how many key federal agencies work. That reset is now ready to begin... and it's critical you start preparing your money immediately.

Rocket Lab Stock Is Shooting Higher Thursday: What's Fueling The Launch?

Rocket Lab USA Inc (NASDAQ:RKLB) shares are trading higher Thursday after the company announced it was selected by Kratos Defense & Security Solutions Inc (NASDAQ:KTOS) to provide a hypersonic test flight for the U.S. Department of Defense (DOD).

The Most Important "AI Stock" You've Never Heard Of - Ad

The AI revolution is moving faster than anyone expected. But what no one is talking about is the one company AI simply can't exist without. It may be the single most important AI investment, yet most people don't even know its name. For now. The moment Wall Street catches on, this $20 stock could explode.

Apple's AI Team Undergoes Major Restructuring Amidst Performance Concerns

Apple Inc. (NASDAQ: AAPL) has embarked on a major overhaul of its artificial intelligence (AI) and machine learning divisions, shifting elements to different departments within the organization.

World Economic Forum: "Arguably the Most Exciting Human Discovery Since Fire" - Ad

Sam Altman, Bill Gates, and Mark Zuckerberg are all investing vast sums of money into a radical technology. According to Bloomberg, this could become 10 times bigger than AI, quantum computing, electric vehicles, cryptocurrencies, and robotics combined. And one stock is at the center of it all.

CEOs Say Container Trade Growth Increasingly Tracks Global GDP, But Tariff Risks Loom

CEOs say that container trade growth is increasingly tracking global GDP, signaling a stable market, but tariff risks loom.

This Intercept Stopped the Gold Sector Cold - Ad

114.26 g/t over 10.6m. That's not a typo. And it wasn't deep exploration-it was in an active mining zone.

Submarine designers in Connecticut say they'll strike on May 18 if contract deal isn't reached

GROTON, Conn. (AP) — About 2,500 workers at Electric Boat shipyard in Connecticut plan to strike on May 18 if a tentative contract agreement is not reached with the submarine builder, the union president announced during a rally Thursday.

Trump's Crypto Blueprint Unveils This Infrastructure Powerhouse - Ad

One blockchain token sits at the heart of Washington's pro-crypto agenda. Institutions are loading up while it still trades at a discount. Here's how to get in for $3.

Most Recent

Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.

Copyright trendadvisor.net
Privacy Policy | Terms of Service